Grants per year
Personal profile
Training Experience
| 2012 | Residency, Northwestern University, Feinberg School of Medicine |
| 2015 | Fellowship, Northwestern University, Feinberg School of Medicine |
Education/Academic qualification
MD, University of Texas Southwestern Medical Center
… → 2009
Fingerprint
Dive into the research topics where Nisha Anjali Mohindra is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 7 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants
-
Prot #BTCRC-LUN19-396: A Phase II Study of Adjuvant Treatment with Cisplatin-Based Chemotherapy Plus Concomitant Atezolizumab in Patients with Stage I (Tumors ≥ 4cm), IIA, IIB, and Select IIIA [T3N1, T4N0-1] Resected Non-Small Cell Lung Cancer (NSCLC) and
Hoosier Cancer Research Network, Inc., Genentech, Inc.
10/21/20 → 10/21/23
Project: Research project
-
Prot #D9103C00001: A Phase III, Randomized, Placebo-controlled, Double-blind, Multi-center, International Study of Durvalumab Following Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients with Unresected Stage I/II Lymph-node Negative
AstraZeneca Pharmaceuticals LP
12/20/19 → 12/20/22
Project: Research project
-
54679793: Using the Novel 4R Patient Care Sequences to Improve the Duration and Outcomes of NSCLC Patients Receiving Targeted Treatment
12/16/19 → 12/31/21
Project: Research project
Research Output
-
The Impact of Beta Blockers on Survival Outcomes in Patients With Non–small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors
Oh, M. S., Guzner, A., Wainwright, D. A., Mohindra, N. A., Chae, Y. K., Behdad, A. & Villaflor, V. M., Jan 2021, In: Clinical Lung Cancer. 22, 1, p. e57-e62Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Management of immunotherapy-related toxicities, version 1.2020 featured updates to the NCCN guidelines
Thompson, J. A., Schneider, B. J., Brahmer, J., Andrews, S., Armand, P., Bhatia, S., Budde, L. E., Costa, L., Davies, M., Dunnington, D., Ernstoff, M. S., Frigault, M., Kaffenberger, B. H., Lunning, M., McGettigan, S., McPherson, J., Mohindra, N. A., Naidoo, J., Olszanski, A. J., Oluwole, O. & 12 others, , 2020, In: JNCCN Journal of the National Comprehensive Cancer Network. 18, 3, p. 231-241 11 p.Research output: Contribution to journal › Article › peer-review
Open Access19 Scopus citations -
Metastatic Thymoma Harboring a Deleterious BRCA2 Mutation Derives Durable Clinical Benefit from Olaparib
Principe, D. R., Kamath, S. D., Munshi, H. G. & Mohindra, N. A., Apr 1 2020, In: Oncologist. 25, 4, p. 301-305 5 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Patient-reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial
Steffen McLouth, L. E., Zhao, F., Owonikoko, T. K., Feliciano, J. L., Mohindra, N. A., Dahlberg, S. E., Wade, J. L., Srkalovic, G., Lash, B. W., Leach, J. W., Leal, T. A., Aggarwal, C., Cella, D., Ramalingam, S. S. & Wagner, L. I., Oct 1 2020, In: Cancer medicine. 9, 20, p. 7511-7523 13 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement
Al-Adra, D. P., Hammel, L., Roberts, J., Woodle, E. S., Levine, D., Mandelbrot, D., Verna, E., Locke, J., D'Cunha, J., Farr, M., Sawinski, D., Agarwal, P. K., Plichta, J., Pruthi, S., Farr, D., Carvajal, R., Walker, J., Zwald, F., Habermann, T., Gertz, M. & 15 others, , 2020, (Accepted/In press) In: American Journal of Transplantation.Research output: Contribution to journal › Review article › peer-review
1 Scopus citations